search
Back to results

Bilateral Ultrasound Guided Quadratus Lumborum Versus Lumbar Epidural Block on Postoperative Analgesia, and Inflammatory Response in Abdominal Surgery

Primary Purpose

Postoperative Pain, Inflammatory Response

Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Ultrasound quadratus lumborum block with bupivacaine 25%
lumbar epideural block with bupivacaine 25%
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA II, III
  • Weight 50 - 85 kg.
  • Scheduled for major lower abdominal cancer surgery (radical cystectomy, total abdominal hysterectomy).

Exclusion Criteria:

  • Patients with a history of relevant drug allergy.
  • Coagulation disorders.
  • Opioid dependence.
  • Sepsis.
  • Local infection at the vicinity of the block site.
  • Patients with psychiatric illnesses that would interfere with perception and assessment of pain

Sites / Locations

  • South Egypt Cancer InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

quadratus lumborum block

lumbar epideural block

Arm Description

received pre-emptive ultrasound-guided quadratus lumborum block with 25 mL of 0.25% bupivacaine on each side of the abdominal wall before induction of GA.

received pre-emptive lumbar epidural block with 15 mL of 0.25% bupivacaine before induction of GA.

Outcomes

Primary Outcome Measures

postoperative pain
postoperative pain intensity.

Secondary Outcome Measures

postoperative inflammatory response
inflammatory response represented by the levels of: interleukins 1,6, and tumor necrosis factor alpha
side effects
sedation, nausea, vomiting, and respiratory depression

Full Information

First Posted
May 15, 2019
Last Updated
July 2, 2019
Sponsor
Assiut University
search

1. Study Identification

Unique Protocol Identification Number
NCT03958942
Brief Title
Bilateral Ultrasound Guided Quadratus Lumborum Versus Lumbar Epidural Block on Postoperative Analgesia, and Inflammatory Response in Abdominal Surgery
Official Title
Effect of Bilateral Ultrasound Guided Quadratus Lumborum Block Versus Lumbar Epidural Block on Postoperative Analgesia, and Inflammatory Response Following Major Lower Abdominal Cancer Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Unknown status
Study Start Date
June 1, 2019 (Actual)
Primary Completion Date
January 1, 2020 (Anticipated)
Study Completion Date
March 1, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study aims at comparing the effects of bilateral ultrasound-guided quadratus lumborum block versus lumbar epidural block on postoperative analgesia and inflammatory response following major lower abdominal cancer surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain, Inflammatory Response

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
quadratus lumborum block
Arm Type
Active Comparator
Arm Description
received pre-emptive ultrasound-guided quadratus lumborum block with 25 mL of 0.25% bupivacaine on each side of the abdominal wall before induction of GA.
Arm Title
lumbar epideural block
Arm Type
Active Comparator
Arm Description
received pre-emptive lumbar epidural block with 15 mL of 0.25% bupivacaine before induction of GA.
Intervention Type
Other
Intervention Name(s)
Ultrasound quadratus lumborum block with bupivacaine 25%
Intervention Description
echogenic needle will be inserted in-plane with the ultrasound beam in a posterior-to-anterior direction through the quadratus lumborum muscle until the ventral fascia of the muscle penetrated. At this point, the needle directed toward the fascial plan between the quadratus lumborum and the Psoas muscle
Intervention Type
Other
Intervention Name(s)
lumbar epideural block with bupivacaine 25%
Intervention Description
lumbar epidural will be performed for patients in group II using a 16-gauge Touhy epidural needle by a median approach. The T12 - L1 or L1 - L2 interspaces will be chosen for the injection. The epidural space identified by the loss of resistance technique.
Primary Outcome Measure Information:
Title
postoperative pain
Description
postoperative pain intensity.
Time Frame
first 24 hours postoperatively
Secondary Outcome Measure Information:
Title
postoperative inflammatory response
Description
inflammatory response represented by the levels of: interleukins 1,6, and tumor necrosis factor alpha
Time Frame
first 24 hours postoperatively
Title
side effects
Description
sedation, nausea, vomiting, and respiratory depression
Time Frame
first 24 hours postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA II, III Weight 50 - 85 kg. Scheduled for major lower abdominal cancer surgery (radical cystectomy, total abdominal hysterectomy). Exclusion Criteria: Patients with a history of relevant drug allergy. Coagulation disorders. Opioid dependence. Sepsis. Local infection at the vicinity of the block site. Patients with psychiatric illnesses that would interfere with perception and assessment of pain
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ahmad M Abd El-Rahman, M.D.
Phone
00201149606060
Email
ahmad23679@gmail.com
Facility Information:
Facility Name
South Egypt Cancer Institute
City
Assiut
ZIP/Postal Code
171516
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Moaaz El tohamy

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Bilateral Ultrasound Guided Quadratus Lumborum Versus Lumbar Epidural Block on Postoperative Analgesia, and Inflammatory Response in Abdominal Surgery

We'll reach out to this number within 24 hrs